River & Mercantile Asset Management LLP Bristol Myers Squibb CO Transaction History

River & Mercantile Asset Management LLP

$361 Million
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $5,517 - $6,256	-115 Reduced 1.0%	11,431 $619,000
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $9,114 - $10,875	-188 Reduced 1.6%	11,546 $592,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $43,185 - $48,288	-746 Reduced 5.98%	11,734 $681,000
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $15,927 - $17,685	-250 Reduced 1.96%	12,480 $799,000
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $36,797 - $41,736	-560 Reduced 4.21%	12,730 $882,000
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $99,296 - $117,580	-1,450 Reduced 9.84%	13,290 $956,000
Q3 2022 Nov 18, 2022	SELL	$0.13 - $76.84 $123 - $72,998	-950 Reduced 6.05%	14,740 $1.05 Million
Q3 2022 Nov 15, 2022	SELL	$0.13 - $76.84 $104 - $61,472	-800 Reduced 4.85%	15,690 $928,000
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $320,254 - $352,711	-4,410 Reduced 21.1%	16,490 $1.27 Million
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $279,412 - $325,729	5,210 Added 33.21%	20,900 $1.3 Million
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $130,548 - $146,828	2,200 Added 16.31%	15,690 $991,000
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $6.16 Million - $6.99 Million	-106,760 Reduced 88.78%	13,490 $836,000
Q3 2020 Mar 01, 2021	SELL	$57.43 - $63.64 $504,809 - $559,395	-8,790 Reduced 6.81%	120,250 $7.25 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $234,888 - $260,287	4,090 Added 3.27%	129,040 $7.78 Million
Q2 2020 Mar 01, 2021	SELL	$54.82 - $64.09 $481,867 - $563,351	-8,790 Reduced 6.57%	124,950 $7.34 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $213,852 - $250,015	-3,901 Reduced 2.83%	133,740 $7.86 Million
Q1 2020 Mar 01, 2021	SELL	$46.4 - $67.43 $407,856 - $592,709	-8,790 Reduced 6.0%	137,641 $7.67 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $1.34 Million - $1.95 Million	28,900 Added 24.59%	146,431 $8.16 Million
Q2 2019 Sep 11, 2019	BUY	$44.62 - $49.34 $5.24 Million - $5.8 Million	117,531 New	117,531 $0
Q2 2019 Aug 27, 2019	SELL	$44.62 - $49.34 $5.18 Million - $5.72 Million	-116,031 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$45.12 - $53.8 $530,160 - $632,150	11,750 Added 11.27%	116,031 $5.54 Million
Q4 2018 Feb 15, 2019	BUY	$48.76 - $63.23 $2.92 Million - $3.79 Million	59,881 Added 134.87%	104,281 $5.42 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $671,104 - $772,576	-11,200 Reduced 20.14%	44,400 $0
Q3 2017 Oct 23, 2017	BUY	$55.23 - $63.74 $3.07 Million - $3.54 Million	55,600	55,600 $3.54 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of River & Mercantile Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on River & Mercantile Asset Management LLP with notifications on news.

Account